--- title: "JD Health International Inc. (86618.HK)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/86618.HK.md" symbol: "86618.HK" name: "JD Health International Inc." industry: "Drug Retail" --- # JD Health International Inc. (86618.HK) | Item | Detail | |------|--------| | Industry | Drug Retail | | Location | HK Market | | Website | [ir.jdhealth.com](https://ir.jdhealth.com) | ## Company Profile JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People’s Republic of China. It provides online medical consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services, as well as inte... ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-18T04:30:12.000Z **Overall: B (0.26)** **Industry**: Drug Retail | Metric | Value | |--------|-------| | Industry Ranking | 2 / 7 | | Industry Median | B | | Industry Average | B | - **Style**: Blend - Stocks in which the company has both growth and mature businesses. - **Scale**: Large - The company has stable operations, allowing for dependable long-term returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 18.89% | | | Net Profit YoY | 80.36% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 2.95 | | | Dividend Ratio | 0.00% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 193.69B | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 73.65B | | **Multi Score**: B #### Profit Score: B | Indicator | Value | Rating | |-----------|-------|--------| | ROE | 8.58% | B | | Profit Margin | 7.25% | B | | Gross Margin | 25.20% | C | #### Growth Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 18.89% | B | | Net Profit YoY | 80.36% | A | | Total Assets YoY | 16.72% | A | | Net Assets YoY | 11.19% | B | #### Cash Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | 1379.04% | B | | OCF YoY | 18.89% | B | #### Operating Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 0.89 | B | #### Debt Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 26.11% | B | ```chart-data:radar { "title": "Longbridge Financial Score - JD Health International Inc.", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "B", "indicators": [ { "name": "ROE", "value": "8.58%", "rating": "B" }, { "name": "Profit Margin", "value": "7.25%", "rating": "B" }, { "name": "Gross Margin", "value": "25.20%", "rating": "C" } ] }, { "name": "Growth", "grade": "B", "indicators": [ { "name": "Revenue YoY", "value": "18.89%", "rating": "B" }, { "name": "Net Profit YoY", "value": "80.36%", "rating": "A" }, { "name": "Total Assets YoY", "value": "16.72%", "rating": "A" }, { "name": "Net Assets YoY", "value": "11.19%", "rating": "B" } ] }, { "name": "Cash", "grade": "B", "indicators": [ { "name": "Cash Flow Margin", "value": "1379.04%", "rating": "B" }, { "name": "OCF YoY", "value": "18.89%", "rating": "B" } ] }, { "name": "Operating", "grade": "B", "indicators": [ { "name": "Turnover", "value": "0.89", "rating": "B" } ] }, { "name": "Security", "grade": "B", "indicators": [ { "name": "Gearing Ratio", "value": "26.11%", "rating": "B" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | JD HEALTH (HK.6618) | B | B | B | B | B | B | | 02 | JD HEALTH-R (HK.86618) | B | B | B | B | B | B | | 03 | ALI HEALTH (HK.241) | B | B | A | B | B | B | | 04 | PA GOODDOCTOR (HK.1833) | C | B | C | B | A | B | | 05 | FANGZHOU JIANKE (HK.6086) | D | A | A | E | D | C | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | 36.27 | 1/7 | 39.87 | 36.13 | 27.60 | | PB | 2.95 | 4/7 | 3.21 | 2.81 | 2.04 | | PS (TTM) | 2.63 | 4/7 | 2.86 | 2.50 | 1.92 | | Dividend Yield | 0.00% | - | - | - | - | ## Institutional View ### Analyst Rating Distribution > As of 2026-02-08T16:00:00.000Z Total Analysts: **1** | Rating | Count | Percentage | |--------|-------|-----------| | Buy | 1 | 100% | | Overweight | 0 | 0% | | Hold | 0 | 0% | | Underweight | 0 | 0% | | Sell | 0 | 0% | ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 53.35 | | Highest Target | 68.30 | | Lowest Target | 68.30 | ## References - [Company Overview](https://longbridge.com/en/quote/86618.HK/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/86618.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/86618.HK/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.